| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mutS homolog 2 | 0.406 | 0.808 | 0.90 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2001 | 2008 | ||||||||
|
macrophage stimulating 1 receptor | 0.542 | 0.808 | 7.9E-37 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2009 | ||||||||
|
myosin IXB | 0.644 | 0.615 | 1.00 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 2006 | 2016 | ||||||||
|
N-acetyltransferase 2 | 0.451 | 0.885 | 3.3E-06 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2005 | 2014 | ||||||||
|
neutrophil cytosolic factor 4 | 0.644 | 0.615 | 9.0E-08 |
|
disease | 0.450 | None | 0.714 | 1 | 0 | 2007 | 2017 | ||||||||
|
NFKB inhibitor alpha | 0.487 | 0.885 | 0.99 |
|
disease | 0.060 | None | 1.000 | 1 | 0 | 2004 | 2014 | ||||||||
|
NK2 homeobox 3 | 0.716 | 0.231 | 0.95 |
|
disease | 0.400 | None | 0.944 | 1 | 0 | 2007 | 2019 | ||||||||
|
NLR family pyrin domain containing 1 | 0.502 | 0.769 | 5.0E-19 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2008 | 2013 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
nucleotide binding oligomerization domain containing 1 | 0.541 | 0.769 | 2.5E-18 |
|
disease | 0.100 | None | 1.000 | 2 | 0 | 2002 | 2019 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 1.000 | moderate | 0.937 | 60 | 0 | 1998 | 2019 | ||||||||
|
nitric oxide synthase 1 | 0.408 | 0.885 | 1.00 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2007 | 2013 | ||||||||
|
nuclear receptor subfamily 1 group I member 2 | 0.418 | 0.846 | 7.3E-09 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2004 | 2019 | ||||||||
|
neurotrophin 3 | 0.519 | 0.808 | 0.93 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
pancreatic and duodenal homeobox 1 | 0.530 | 0.654 | 1.8E-02 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2007 | 2018 | ||||||||
|
proline and serine rich 1 | 0.931 | 0.038 | 0.71 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
prostaglandin E receptor 4 | 0.558 | 0.731 | 0.98 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 2007 | 2017 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
disease | 0.080 | None | 1.000 | 2 | 0 | 1998 | 2019 | ||||||||
|
S100 calcium binding protein A12 | 0.488 | 0.846 | 0.48 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 1980 | 2008 | ||||||||
|
solute carrier family 11 member 1 | 0.525 | 0.846 | 1.5E-19 |
|
disease | 0.400 | None | 0.750 | 2 | 0 | 1997 | 2019 | ||||||||
|
solute carrier family 22 member 4 | 0.603 | 0.769 | 1.8E-08 |
|
disease | 0.500 | None | 0.896 | 5 | 0 | 2003 | 2017 | ||||||||
|
solute carrier family 22 member 5 | 0.608 | 0.731 | 5.3E-16 |
|
disease | 0.400 | None | 0.912 | 6 | 0 | 2003 | 2016 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2005 | 2018 |